关注
Mohsin Shah, MBBS, MSCE
Mohsin Shah, MBBS, MSCE
Associate Director, Global Integrated Evidence - Epidemiology & RWE Oncology at Boehringer Ingelheim
在 alumni.upenn.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Perceived stress, sources and severity of stress among medical undergraduates in a Pakistani medical school
M Shah, S Hasan, S Malik, CT Sreeramareddy
BMC medical education 10, 1-8, 2010
7852010
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review
N Abdel-Wahab, M Shah, M Lopez-Olivo, ME Suarez-Almazor
Annals of Internal Medicine, 2018
4792018
Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor
PloS one 11 (7), e0160221, 2016
4732016
RESEARCH: What, Why and How? A Treatise from Researchers to Researchers
PM Kasi
What, Why and How? 1, 327, 2009
115*2009
Myositis as an adverse event of immune checkpoint blockade for cancer therapy
M Shah, JH Tayar, N Abdel-Wahab, ME Suarez-Almazor
Seminars in arthritis and rheumatism, 2018
1092018
Self-reported tobacco smoking practices among medical students and their perceptions towards training about tobacco smoking in medical curricula: A cross-sectional …
CT Sreeramareddy, S Suri, RG Menezes, HNH Kumar, M Rahman, ...
Substance abuse treatment, prevention, and policy 5, 1-9, 2010
882010
Polycystic ovary syndrome: implication for drug metabolism on assisted reproductive techniques—a literature review
E Reyes-Muñoz, T Sathyapalan, P Rossetti, M Shah, M Long, M Buscema, ...
Advances in Therapy 35, 1805-1815, 2018
722018
Treatment with metformin and combination of metformin plus pioglitazone on serum levels of IL-6 and IL-8 in polycystic ovary syndrome: a randomized clinical trial
M Shah, A Ali, MO Malik, F Rehman, H Badshah, E Ehtesham, SG Vitale
Hormone and Metabolic Research 51 (11), 714-722, 2019
522019
Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome
M Zahra, M Shah, A Ali, R Rahim
Hormone and Metabolic Research 49 (02), 103-108, 2017
512017
Assessment of relationship of serum neurokinin-b level in the pathophysiology of pre-eclampsia: A case–control study
H Salman, M Shah, A Ali, A Aziz, SG Vitale
Advances in Therapy 35, 1114-1121, 2018
332018
Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab.
I Mian, M Yang, H Zhao, M Shah, A Diab, V Shannon, A Patel, RN Amaria, ...
Journal of Clinical Oncology 34 (15_suppl), 3047-3047, 2016
272016
Diagnosis and management of immune‐related adverse effects of immune checkpoint therapy in the emergency department
SCJ Yeung, A Qdaisat, P Chaftari, D Lipe, J Merlin, E Rajha, A Wechsler, ...
Journal of the American College of Emergency Physicians Open, 0
26
The physiological responses of yogic breathing techniques: A case-control study
S Malik, M Shah, S Hasan, M Bilal
Journal of Exercise Physiologyonline 14 (3), 74-9, 2011
142011
Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 …
MN Syed, M Shah, DB Shin, MT Wan, KL Winthrop, JM Gelfand
Journal of the American Academy of Dermatology 84 (1), 161-163, 2021
132021
The outcome of checkpoint inhibitor therapy in patients with cancer and solid organ transplant: A systematic review of the literature.
NA Hassan, A Abudayyeh, M Shah, DH Johnson, ME Suarez-Almazor, ...
Journal of Clinical Oncology 36 (5_suppl), 41-41, 2018
132018
The physician's unique role in preventing violence: a neglected opportunity?
JC Umhau, K Trandem, M Shah, DT George
BMC medicine 10, 1-8, 2012
132012
Extramedullary plasmacytoma involving the trachea: a case report and literature review
MN Jizzini, M Shah, SCJ Yeung
The Journal of Emergency Medicine 57 (3), e65-e67, 2019
122019
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L) 1 monotherapies in …
M Shah, RA Hubbard, R Mamtani, ME Marmarelis, S Hennessy
Pharmacoepidemiology and drug safety 31 (10), 1121-1126, 2022
102022
SARS-CoV-2 and anti-cardiolipin antibodies
M Jizzini, M Shah, K Zhou
Clinical Medicine Insights: Case Reports 13, 1179547620980381, 2020
102020
Safety of immune checkpoint blockade in patients with cancer and preexisting autoimmune diseases and/or chronic inflammatory disorders
M Shah, MN Jizzini, IE Majzoub, CC Qdaisat, A, Reyes-Gibby, ...
Journal of Immunotherapy and Precision Oncology 2, 2019
102019
系统目前无法执行此操作,请稍后再试。
文章 1–20